Vepdegestrant (ARV-471) yielded a statistically significant and clinically meaningful improvement in progression-free ...

The presence of biomarkers, even in small amounts, can shape the course of treatment for a patient, says Andy Guinigundo, MSN, RN, CNP, ANP-BC.

BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...

Seth Eisenberg, ASN, RN, OCN, BMTCN, explained his research on a toilet cover for oncology nurses to potentially reduce ...

Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during ...

Experts discuss treatment options for HER2-positive metastatic breast cancer following progression on trastuzumab deruxtecan (T-DXd), weighing real-world data on tucatinib-capecitabine-trastuzumab ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Experts discuss how, discuss patient experiences with an oral chemotherapy regimen, highlighting benefits like treatment autonomy, challenges such as pill burden and gastrointestinal toxicities, and ...

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

While ambient particle levels differed by HEPA filter status, Splashblocker significantly reduced particles emitted from ...

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...